Bristol Myers Squibb Co
BMY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000014272
In the last 90 days, Bristol Myers Squibb Co insiders filed 0 open-market purchases and 2 sales; 2,529 institutions reported holding it in 13F filings for Q2 2026, worth $96.7B in total; no superinvestor holds it.
Other share classesCELG.RI
Holders of 5% or more of BMY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bristol Myers Squibb Co, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.10%143.6M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Bristol Myers Squibb Co, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 20265:08 PM ET | Vanguard Capital Management LLC | 13G | 7.49%153.1M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20264:44 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Oct 31, 20259:48 AM ET | JPMorgan Chase & Co | 13G/A | 4.00%81.9M shares | −1.10 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Apr 25, 20252:57 PM ET | JPMorgan Chase & Co | 13G | 5.10%104.7M shares | New | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 7.10%143.6M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bristol Myers Squibb Co shares.
No Form 144 notices for Bristol Myers Squibb Co are on file.